Zhu, Y., & Shah, K. (2014). Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384. Landes Bioscience.
Chicago Style CitationZhu, Yanni, i Khalid Shah. Multiple Lesions in Receptor Tyrosine Kinase Pathway Determine Glioblastoma Response to Pan-ERBB Inhibitor PF-00299804 and PI3K/mTOR Dual Inhibitor PF-05212384. Landes Bioscience, 2014.
Cita MLAZhu, Yanni, i Khalid Shah. Multiple Lesions in Receptor Tyrosine Kinase Pathway Determine Glioblastoma Response to Pan-ERBB Inhibitor PF-00299804 and PI3K/mTOR Dual Inhibitor PF-05212384. Landes Bioscience, 2014.
Atenció: Aquestes cites poden no estar 100% correctes.